HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mechanism of the nongenomic effects of estrogen on intestinal myeloperoxidase activity following trauma-hemorrhage: up-regulation of the PI-3K/Akt pathway.

Abstract
As studies indicate that genomic and nongenomic pathways are involved in mediating the salutary effects of 17beta-estradiol (E2) following trauma-hemorrhage, we examined if the nongenomic effects of E2 on attenuation of intestinal injury after trauma-hemorrhage involve the PI-3K/Akt pathway. Male Sprague-Dawley rats ( approximately 300 g body weight) underwent trauma-hemorrhage (mean blood pressure 40 mmHg for 90 min), followed by resuscitation. E2 conjugated to BSA (E2-BSA; 1 mg/Kg E2), with or without an estrogen receptor antagonist (ICI 182,780), a PI-3K inhibitor (Wortmannin), or vehicle, was injected i.v. during resuscitation. At 2 h after trauma-hemorrhage or sham operation, intestinal myeloperoxidase (MPO) activity, ICAM-1, cytokine-induced neutrophil chemoattractant (CINC)-1, CINC-3, and IL-6 levels were measured (n=6 rats/group). Intestinal PI-3K, phosphorylation of Akt (p-Akt), and Akt protein expressions were also determined. One-way ANOVA and Tukey's test were used for statistical analysis. The results indicated that trauma-hemorrhage increased intestinal MPO activity and ICAM-1, CINC-1, CINC-3, and IL-6 levels. These parameters were improved significantly in the E2- or E2-BSA-treated rats subjected to trauma-hemorrhage. Although trauma-hemorrhage decreased intestinal PI-3K and p-Akt protein expressions, E2 or E2-BSA treatment following trauma-hemorrhage prevented such decreases in intestinal PI-3K and p-Akt protein expressions. Coadministration of ICI 182,780 or Wortmannin abolished the beneficial effects of E2-BSA on attenuation of intestinal injury following trauma-hemorrhage. Thus, the PI-3K/Akt pathway plays a critical role in mediating the nongenomic, salutary effects of E2 on attenuation of shock-induced intestinal tissue damage.
AuthorsHuang-Ping Yu, Ya-Ching Hsieh, Takao Suzuki, Mashkoor A Choudhry, Martin G Schwacha, Kirby I Bland, Irshad H Chaudry
JournalJournal of leukocyte biology (J Leukoc Biol) Vol. 82 Issue 3 Pg. 774-80 (Sep 2007) ISSN: 0741-5400 [Print] United States
PMID17586659 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Androstadienes
  • Chemokine CXCL1
  • Chemokines, CXC
  • Cxcl1 protein, rat
  • Estrogen Antagonists
  • Estrogen Receptor Modulators
  • Interleukin-6
  • Phosphoinositide-3 Kinase Inhibitors
  • Protein Kinase Inhibitors
  • Receptors, Estrogen
  • Intercellular Adhesion Molecule-1
  • Fulvestrant
  • Estradiol
  • Peroxidase
  • Proto-Oncogene Proteins c-akt
  • Wortmannin
Topics
  • Androstadienes (pharmacology)
  • Animals
  • Blotting, Western
  • Chemokine CXCL1
  • Chemokines, CXC (metabolism)
  • Estradiol (analogs & derivatives, pharmacology)
  • Estrogen Antagonists (pharmacology)
  • Estrogen Receptor Modulators (pharmacology)
  • Fulvestrant
  • Genome
  • Intercellular Adhesion Molecule-1 (metabolism)
  • Interleukin-6 (metabolism)
  • Intestine, Small (drug effects, enzymology)
  • Male
  • Peroxidase (metabolism)
  • Phosphatidylinositol 3-Kinases (metabolism)
  • Phosphoinositide-3 Kinase Inhibitors
  • Phosphorylation
  • Protein Kinase Inhibitors (pharmacology)
  • Proto-Oncogene Proteins c-akt (metabolism)
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Estrogen (antagonists & inhibitors, metabolism)
  • Shock, Hemorrhagic (drug therapy, metabolism)
  • Up-Regulation
  • Wortmannin
  • Wounds and Injuries (drug therapy, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: